Searched for
CUTTING EDGE THERAPIES
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...- Novo Nordisk price cuts set to shake up India’s GLP-1 market, challenge genericsNovo Nordisk is slashing prices for its diabetes and weight loss drugs Ozempic and Wegovy in India. This move aims to make these treatments...
- Immortality or irony? Biohacker spending $2 million a year to defy death has one chilling message for his hatersAs internet trolls mock Bryan Johnson’s quest to “live forever,” the biohacker delivers a confident, philosophical reply: maybe it's not hi...
- AIG Hospitals to invest Rs 800 crore in new oncology centreAIG Hospitals is investing Rs 800 crore in a new dedicated oncology centre in Hyderabad, featuring the cutting-edge Proton Beam Therapy sys...
- East Ocyon Bio closes $4.2M Seed round led by Aeravti Ventures and Micro LabsEast Ocyon Bio aims to reshape India’s role in the global biotech landscape, creating an ecosystem where pioneering therapies are developed...
- Tech millionaire claims to have slowed down aging by DNA editing. Will this technology help humans live forever?Millionaire Bryan Johnson visited a remote island to extend his life. He spent $20,000 for a treatment that would keep him young forever.
- Cipla makes additional investment in German mRNA biotechEthris' has four potential drugs under development pipeline, of which one is for treating uncontrolled asthma and three other for primary c...
- Sanofi plans to split consumer health unit to narrow focusSanofi is reviewing options for the potential split, but said the most likely course would be a “capital markets transaction” to form a sep...
- Affordable gene and cell therapies need of the hour: Dr Kapil Bharti, Scientific Director, National Eye InstituteLimitless potential for future global advancements in gene therapies is originating from India, said Dr David Gamm.
- Cipla invests in Ethris for mRNA-based inhalation therapiesThe investment will facilitate a long-term strategic partnership between Cipla and Ethris for the development of messenger RNA (mRNA)-based...
- Cipla to invest 15 million euros in Germany’s Ethris to expand respiratory portfolioThe investment will facilitate a long-term strategic partnership between Cipla and Ethris for development of messenger RNA (mRNA)-based the...
- Immuneel Therapeutics raises $15 million in fundingImmuneel Therapeutics is working on developing its own pipeline of chimeric antigen receptor T-cell (CAR-T) therapies and other cellular im...
- Cellogen to bring next-gen cancer therapy to India"Chimeric Antigen Receptor cells represent a cutting-edge technology that holds great promise for cancer treatment. We are delighted to off...
- Laurus Labs acquires stake in IIT-Bombay incubated CAR-T cell therapy companyAs per the agreement, Laurus will acquire 26.62% stake (fully diluted basis) for a cash consideration of approximately Rs 46 crores, subjec...
- Pharma companies' charity hope for kids with rare spinal disorderThe rare disease affects one in every 8,000 children. The bigger problem, according to parents and doctors, is the lack of awareness about ...
- Immuneel signs pact with Hospital Clínic de Barcelona to work on cancer therapyThe collaboration opens up opportunities for co-development of advanced assets to be deployed in Spain and India, said Immuneel in a press ...
- Indian-origin scientist finds biomarker predicting chemo success in ovarian cancerThe discovery, by Madhuri Koti from Queen's University in Canada, could lead to better treatment options in the fight against ovarian cance...
- Drug Controller General of India to pharma MNCs: Conduct fruitful clinical trials for IndiansThis is meant to expedite launch of cutting edge therapies in the country, particularly in cases where India has participated during the tr...
- Fortis, TotipotentRX tie up for stem cell centresAs part of the alliance, a stem cell medical board will be created to oversee the medical research programme, ensure execution and monitor ...
- Govt may buy MNC drugs in bulk and sell cheapThe government is examining the possibility of barring multinational companies who hold monopoly over costly, patented drugs and medical de...
Load More
